1-苯基-1,2,3,4-四氢喹啉-2-酮 | 67176-93-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 中文名称: 1-苯基-1,2,3,4-四氢喹啉-2-酮
• 英文名称: 1-phenyl-3,4-dihydroquinolin-2(1H)-one
• 英文别名: 1-phenyl-3,4-dihydro-1H-quinolin-2-one；1-phenyl-3,4-dihydroquinolin-2-one
• CAS: 67176-93-6
• 化学式: C₁₅H₁₃NO
• 分子量: 223.274
• InChiKey: KZVGADOBXOOISP-UHFFFAOYSA-N

物化性质

• 熔点：
  123 °C(Solv: isopropanol (67-63-0))
• 沸点：
  456.7±25.0 °C(Predicted)
• 密度：
  1.187±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  17
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-苯基-1,2,3,4-四氢喹啉-2-酮 在 9-borabicyclo[3.3.1]nonane dimer 、 三乙胺 、 lithium hexamethyldisilazane 作用下， 以 四氢呋喃 、 乙醇 、 水 为溶剂， 反应 6.0h， 生成 3-ethyl-3-(3-methylamino-propyl)-1-phenyl-3,4-dihydro-1H-quinolin-2-one
  参考文献：
  名称：

  1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors

  摘要：

  A novel series of 1-aryl-3,4-dihydro-1H-quinolin-2-ones have been discovered as potent and selective norepinephrine reuptake inhibitors. Efficient synthetic routes have been developed which allow for the multi-gram preparation of both final targets and advanced intermediates for SAR expansion. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.07.038
• 作为产物：
  描述：

  N-羟基-N,3-二苯基丙酰胺 在 三氟甲磺酸 作用下， 反应 4.0h， 以55%的产率得到1-苯基-1,2,3,4-四氢喹啉-2-酮
  参考文献：
  名称：

  Capozzi, Giuseppe; Chimirri, Alba; Grasso, Silvana, Heterocycles, 1984, vol. 22, # 8, p. 1759 - 1762

  摘要：

  DOI：

文献信息

• Synthesis of Cyclic Amidines by Iridium-Catalyzed Deoxygenative Reduction of Lactams and Tandem Reaction with Sulfonyl Azides
  作者：Youliang He、Xiaoming Wang

  DOI：10.1021/acs.orglett.0c03953

  日期：2021.1.1

  An efficient and convenient synthesis of various cyclic amidines has been achieved via iridium-catalyzed deoxygenative reduction of lactams with a silane followed by a one-pot cycloaddition reaction with sulfonyl azides. Using the novel tandem procedure, a large array of cyclic amidines bearing various sized rings were synthesized in good yields from readily available lactams. This methodology has

  通过用硅烷催化的内酰胺的铱催化的内酰胺脱氧还原，然后与磺酰叠氮化物的一锅环加成反应，已经实现了各种环状am的高效便捷合成。使用新颖的串联程序，从容易获得的内酰胺以高收率合成了各种带有各种大小环的环状am。该方法已成功用于带有内酰胺部分的复杂结构的后期多样化。
• Enantioselective Synthesis of C−N Axially Chiral N‐Aryloxindoles by Asymmetric Rhodium‐Catalyzed Dual C−H Activation
  作者：Honghe Li、Xiaoqiang Yan、Jitan Zhang、Weicong Guo、Jijun Jiang、Jun Wang

  DOI：10.1002/anie.201901619

  日期：2019.5.13

  reaction is reported. A variety of C−N axially chiral N‐aryloxindoles have been enantioselectively synthesized by an asymmetric rhodium‐catalyzed dual C−H activation reaction of N‐aryloxindoles and alkynes. High yields and enantioselectivities were obtained (up to 99 % yield and up to 99 % ee). To date, it is also the first example of the asymmetric synthesis of C−N axially chiral compounds by such a C−H

  据报道，第一个对映选择性的Satoh-Miura型反应。通过不对称的铑催化的N-芳基氧吲哚和炔烃的双重C H活化反应，对映选择性地合成了多种C N轴向手性的N-芳基氧吲哚。获得了高产率和对映选择性（高达99％的产率和高达99％的ee）。迄今为止，它也是通过这种CH活化策略不对称合成CNN手性化合物的第一个例子。
• NIS-mediated oxidative arene C(sp²)–H amidation toward 3,4-dihydro-2(1<i>H</i>)-quinolinone, phenanthridone, and <i>N</i>-fused spirolactam derivatives
  作者：Lingang Wu、Yanan Hao、Yuxiu Liu、Qingmin Wang

  DOI：10.1039/c9ob01277j

  日期：——

  A new radical-mediated intramolecular arene C(sp2)-H amidation of 3-phenylpropanamides or [1,1'-biphenyl]-2-carboxamides was developed to prepare a series of 3,4-dihydro-2(1H)-quinolinone and phenanthridone derivatives in moderate to excellent yields (33-94%). Spirolactams could also be obtained using this protocol.

  一种新的自由基介导的3-苯基丙酰胺或[1,1'-联苯] -2-羧酰胺的分子内芳烃C（sp2）-H酰胺化反应制备了一系列3,4-二氢-2（1H）-喹啉酮和菲啶酮衍生物的收率中等至优异（33-94％）。螺内酰胺也可以使用该方案获得。
• [EN] QUINOLONE DERIVATIVES<br/>[FR] DERIVES DE QUINOLONE
  申请人：LILLY CO ELI

  公开号：WO2004096773A1

  公开（公告）日：2004-11-11

  This invention relates to compounds of formula (I) where -X-, n, R1, R3 and Ar- have the values defined herein, their preparation and use as norepinephrine reuptake inhibitors useful for the treatment of nervous system disorders

  这项发明涉及到式(I)的化合物，其中-X-、n、R1、R3和Ar-具有本文中定义的值，它们的制备和用途作为去甲肾上腺素再摄取抑制剂，可用于治疗神经系统疾病。
• .beta.-carboline derivative
  申请人：Tanabe Seiyaku Co., Ltd.

  公开号：US05434148A1

  公开（公告）日：1995-07-18

  Disclosed are .beta.-carboline derivatives represented by the formula: ##STR1## wherein R.sup.1 represents hydrogen atom, a lower alkyl group, a lower alkoxy group or hydroxy group; R.sup.5 represents hydrogen atom, or R.sup.1 and R.sup.5 are bonded to represent a lower alkylenedioxy group; R.sup.2 represents hydrogen atom, a halogen atom, a lower alkoxy group or hydroxy group; R.sup.3 represents hydrogen atom, a carbamoyl lower alkyl group, a lower alkyl group, a carboxy lower alkyl group or a lower alkoxycarbonyl lower alkyl group; R.sup.4 represents hydrogen atom, a lower alkyl group, a carboxy lower alkyl group, a lower alkoxycarbonyl lower alkyl group, a lower alkanoyl group, an arylcarbonyl group, a lower alkanesulfonyl group, a lower alkoxycarbonyl group, an aralkyl group, formyl group or a di(lower alkyl)sulfamoyl group; n represents 0, 1 or 2; and the symbol * represents an asymmetric carbon atom, or a pharmaceutically acceptable salt thereof, and a process for preparing the same.

  本发明涉及一种β-咔啉衍生物，其化学式表示为：##STR1## 其中R1代表氢原子，较低的烷基，较低的烷氧基或羟基；R5代表氢原子，或R1和R5结合形成较低的烷基二氧基基团；R2代表氢原子，卤原子，较低的烷氧基或羟基；R3代表氢原子，氨甲酰较低的烷基，较低的烷基，羧较低的烷基或较低的烷氧羰基较低的烷基；R4代表氢原子，较低的烷基，羧较低的烷基，较低的烷氧羰基较低的烷基，较低的烷酰基，芳基羰基，较低的烷基磺酰基，较低的烷氧羰基，芳基烷基，甲酰基或二（较低的烷基）磺酰基；n代表0、1或2；符号*代表不对称碳原子，或其药学上可接受的盐，以及制备它们的过程。